MARKET

ZGNX

ZGNX

Zogenix
NASDAQ

Real-time Quotes | Nasdaq Last Sale

22.26
-0.93
-4.01%
After Hours: 22.26 0 0.00% 16:00 04/03 EDT
OPEN
23.16
PREV CLOSE
23.19
HIGH
23.67
LOW
21.99
VOLUME
623.87K
TURNOVER
--
52 WEEK HIGH
57.22
52 WEEK LOW
16.65
MARKET CAP
1.20B
P/E (TTM)
-2.2875
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ZGNX stock price target is 54.54 with a high estimate of 76.00 and a low estimate of 25.00.

EPS

ZGNX News

More
  • Mizuho Maintains Buy on Zogenix, Lowers Price Target to $64
  • Benzinga · 4d ago
  • Is Zogenix, Inc. (ZGNX) Going to Burn These Hedge Funds?
  • Insider Monkey · 03/29 17:31
  • Edited Transcript of ZGNX earnings conference call or presentation 2-Mar-20 9:30pm GMT
  • Thomson Reuters StreetEvents · 03/24 11:52
  • Co-founder & Chairman Cam Garner Just Bought Shares In Zogenix, Inc. (NASDAQ:ZGNX)
  • Simply Wall St. · 03/21 14:08

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About ZGNX

Zogenix, Inc. is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other CNS disorders. Its primary area of therapeutic focus is epilepsy and related seizure disorders. Its lead product candidate, ZX008, is a low-dose fenfluramine for the treatment of seizures associated with Dravet syndrome. ZX008 has received orphan drug designation in the United States and European Union (EU), for the treatment of Dravet syndrome. The Company has an additional product candidate, Relday (risperidone once-monthly long-acting injectable) for the treatment of schizophrenia. Relday is a long-acting injectable formulation of risperidone. Risperidone is used to treat the symptoms of schizophrenia and bipolar disorder in adults and teenagers 13 years of age and older. It has completed the Phase I program for Relday.
More

Webull offers kinds of Zogenix, Inc. stock information, including NASDAQ:ZGNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZGNX stock news, and many more online research tools to help you make informed decisions.